Shu Chih Liu

发表

Functional genetic polymorphisms in CYP2C19 gene in relation to cardiac side effects and treatment dose in a methadone maintenance cohort.

C. Hsiao, Yu-Li Liu, Keh‐ming Lin, 2013, Omics : a journal of integrative biology.

APBB2 is associated with amphetamine use and plasma beta-amyloids in patients receiving methadone maintenance treatment

Yu-Li Liu, Sheng-Chang Wang, Andrew C H Chen, 2018, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

CYP2B6 Polymorphisms Influence the Plasma Concentration and Clearance of the Methadone S-Enantiomer

H. Chan, C. Hsiao, Yu-Li Liu, 2011, Journal of clinical psychopharmacology.

Development of a method to measure methadone enantiomers and its metabolites without enantiomer standard compounds for the plasma of methadone maintenance patients.

Yu-Li Liu, Keh‐ming Lin, Sheng-Chang Wang, 2009, Biomedical chromatography : BMC.

Genetic polymorphisms in the opioid receptor delta 1 (OPRD1) gene are associated with methadone dose in methadone maintenance treatment for heroin dependence

R. Chung, Yu-Li Liu, Hsiao-Hui Tsou, 2020, Journal of Human Genetics.

ABCB1 gene polymorphisms are associated with the severity of major depressive disorder and its response to escitalopram treatment

Y. Chiu, Yu-Li Liu, Keh‐ming Lin, 2010, Pharmacogenetics and genomics.

GRK5 Is Associated with the Regulation of Methadone Dosage in Heroin Dependence

R. Chung, Yu-Li Liu, Hsiao-Hui Tsou, 2018, The international journal of neuropsychopharmacology.

The Association of Genetic Polymorphisms in the &kgr;-Opioid Receptor 1 Gene With Body Weight, Alcohol Use, and Withdrawal Symptoms in Patients With Methadone Maintenance

R. Chung, C. Hsiao, Yu-Li Liu, 2014, Journal of clinical psychopharmacology.

Association of the D-amino acid oxidase gene with methadone dose in heroin dependent patients under methadone maintenance treatment

R. Chung, Yu-Li Liu, Hsiao-Hui Tsou, 2022, Journal of Human Genetics.

CYP1A2 genetic polymorphisms are associated with treatment response to the antidepressant paroxetine.

H. Chan, C. Hsiao, Yu-Li Liu, 2010, Pharmacogenomics.

Genetic polymorphisms of cytochrome P450 enzymes influence metabolism of the antidepressant escitalopram and treatment response.

Yu-Li Liu, C. Fang, Keh‐ming Lin, 2010, Pharmacogenomics.

Genetic polymorphisms in the opioid receptor mu1 gene are associated with changes in libido and insomnia in methadone maintenance patients

Yu-ting Chen, C. Hsiao, Yu-Li Liu, 2012, European Neuropsychopharmacology.

UGT2B7 genetic polymorphisms are associated with the withdrawal symptoms in methadone maintenance patients.

Yu-ting Chen, C. Hsiao, Yu-Li Liu, 2012, Pharmacogenomics.

CYP1A2 genetic polymorphisms are associated with early antidepressant escitalopram metabolism and adverse reactions.

C. Hsiao, Yu-Li Liu, T. Yeh, 2013, Pharmacogenomics.

Genetic polymorphisms in CYP3A4 are associated with withdrawal symptoms and adverse reactions in methadone maintenance patients.

C. Hsiao, Yu-Li Liu, Keh‐ming Lin, 2011, Pharmacogenomics.

Genetic variants in NECTIN4 encoding an adhesion molecule are associated with continued opioid use

R. Chung, Yu-Li Liu, Hsiao-Hui Tsou, 2020, PloS one.

Association of the D-amino acid oxidase gene with methadone dose in heroin dependent patients under methadone maintenance treatment

R. Chung, Yu-Li Liu, Hsiao-Hui Tsou, 2022, Journal of Human Genetics.